 | Up a level |
2022
Brandt, Maximilian Peter, Ruf, C., Dieckmann, K. P., Syring, I, Ruckes, C., Nestler, T., Schmelz, H. U., Dotzauer, R., Hiester, A., Albers, P., Nettersheim, D., Bolenz, C., Loosen, S. H., Heidenreich, A., Pfister, D., Haferkamp, A., Zengerling, F. and Paffenholz, P. (2022). Clinical characteristics, treatment patterns and relapse in patients with clinical stage IS testicular cancer. World J. Urol., 40 (2). S. 327 - 335. NEW YORK: SPRINGER. ISSN 1433-8726
Darr, C., Zschaebitz, S., Niegisch, G., Roghmann, F., Ivanyi, P., Zengerling, F., Paffenholz, P., Biernath, N., Klee, M., Kluemper, N., Tauber, R. L., Hadaschik, B. A., Hilser, T. and Gruenwald, V. (2022). Enfortumab vedotin in metastatic urothelial carcinoma: Retrospective multicentre patient cohort. Ann. Oncol., 33 (7). S. S1342 - 1. AMSTERDAM: ELSEVIER. ISSN 1569-8041
2017
Paffenholz, P., Salem, J., Syring, I., Zengerling, F., Brandt, M. P., Hermann, J., Nestler, T., Schubert, M., Ernst, S., Ruf, C. and Schlenker, B. (2017). GeSRU Testicular Cancer App Staging from the Pocket. Urologe, 56 (8). S. 1044 - 1047. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1433-0563